TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Recipharm AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
392,014
|
473,894
|
397,890 |
| Financial expenses |
670,656
|
4,386,032
|
2,290,937 |
| Earnings before taxes |
3,453,046
|
-5,917,519
|
-14,091 |
| EBITDA |
-184,893
|
-205,865
|
-117,878 |
| Total assets |
13,173,599
|
15,413,024
|
19,719,153 |
| Current assets |
5,056,947
|
8,743,193
|
2,656,132 |
| Current liabilities |
1,593,714
|
2,954,997
|
1,412,956 |
| Equity capital |
5,086,294
|
6,154,698
|
12,017,706 |
| - share capital |
32,835
|
33,959
|
33,785 |
| Employees (average) |
44
|
60
|
67 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.6%
|
39.9%
|
60.9% |
| Turnover per employee |
8,909
|
7,898
|
5,939 |
| Profit as a percentage of turnover |
880.8%
|
-1248.7%
|
-3.5% |
| Return on assets (ROA) |
31.3%
|
-9.9%
|
11.5% |
| Current ratio |
317.3%
|
295.9%
|
188.0% |
| Return on equity (ROE) |
67.9%
|
-96.1%
|
-0.1% |
| Change turnover |
-66,205
|
73,955
|
232,252 |
| Change turnover % |
-14%
|
18%
|
140% |
| Chg. No. of employees |
-16
|
-7
|
3 |
| Chg. No. of employees % |
-27%
|
-10%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.